4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001193125-26-468898
Chief Commercial Officer sold 448 shares at $7.27 ($3,257)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Powl Brian T. · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-19 | Sale : show line 1 in the form 10b5-1 | −448 | $7.27 | $3,257 | 112,817 | D |
| Open-market sales · 448 sh · avg $7.27 · $3,257 | ||||||
Loading xslF345X06/ownership.xml…